Skip to main navigation

Investors

News Archive
Past Events and Presentations
Stock History

News Archive

News Archive

Items Per Page

Year

Oct 19, 2006

U.S. District Court Grants Mylan's Motion to Dismiss the '909 Patent in the Amlodipine Besylate Litigation

Sep 19, 2006

Mylan Declares Quarterly Cash Dividend of $.06 Per Share

Sep 12, 2006

Mylan Announces Final FDA Approval for Topiramate Tablets

Sep 07, 2006

U.S. Court of Appeals Rules in Favor of Mylan in Oxybutynin Patent Litigation

Aug 30, 2006

Mylan Announces Tentative Approval for Fluoxetine Capsules, USP

Aug 28, 2006

Mylan Laboratories to Acquire Up to 71.5% Controlling Interest in Matrix Laboratories

Aug 14, 2006

Mylan Announces Tentative Approval for Venlafaxine Hydrochloride Tablets

Aug 07, 2006

Mylan No Longer Anticipates Additional Generic Transdermal Fentanyl Approvals During Fiscal 2007

Aug 07, 2006

Mylan Reaffirms Fiscal 2007 Adjusted EPS Guidance of $1.35 - $1.55

Jul 26, 2006

Mylan Increases Fiscal 2007 Adjusted Guidance to $1.35 to $1.55 per Diluted Share and Reports Record Diluted EPS of $0.35 for the First Quarter of Fiscal 2007

Pagination

First page
Previous page
…
Page 102
Page 103
Page 104
Page 105
Current page 106
Page 107
Page 108
Page 109
Page 110
…
Next page
Last page

Share

Utility Nav

Privacy Statement
Terms and Conditions

©2025 Mylan N.V. All rights reserved. The Mylan logo is a registered trademark of Mylan Inc.